The Phase III trial will assess hydroxychloroquine as a potential Covid-19 therapy in around 440 participants. Credit: amrothman from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more